ITGR Integer Holdings Corp
Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1114483 · Fiscal year ends 12/31
Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.3%
TTM net income YoY19.3%
TTM EPS YoY22.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR8.0%
Margins
Gross margin24.6%
Operating margin8.2%
Net margin5.7%
FCF margin4.5%
EBITDA margin15.9%
Returns
ROE6.0%
ROA3.1%
ROIC (approx.)5.0%
Asset turnover0.54x
Leverage & solvency
Liabilities / assets49.1%
Debt / equity0.71x
Current ratio3.98x
Interest coverage3.87x
Cash quality & payout
Operating cash flow / net income1.70x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue5.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-02 | 2026Q22026-07-03 | 2026Q12026-04-03 | 2025Q4*2025-12-31 | 2025Q32025-09-26 | 2025Q22025-06-27 | 2025Q12025-03-28 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $449.66M | $464.11M | $439.58M | $472.06M | $467.69M | $476.49M | $437.39M | $449.50M |
| Cost of revenue | $348.10M | $351.17M | $329.99M | $347.30M | $341.53M | $347.34M | $317.07M | $332.70M |
| Gross profit | $101.56M | $112.94M | $109.59M | $124.76M | $126.16M | $129.15M | $120.32M | $116.80M |
| R&D expense | $13.53M | $11.28M | $16.24M | $10.11M | $10.95M | $14.24M | $14.20M | $10.61M |
| SG&A expense | $54.15M | $57.70M | $58.71M | $57.21M | $50.45M | $52.92M | $51.16M | $47.47M |
| Operating income | $28.21M | $34.53M | $31.87M | $55.94M | $56.44M | $59.34M | $49.55M | $57.03M |
| Interest expense | $9.70M | $10.13M | $9.73M | $9.28M | $9.37M | $9.75M | $14.80M | $13.23M |
| Pretax income | $17.51M | $23.29M | $20.35M | $46.81M | $45.99M | $45.60M | -$13.00M | $39.26M |
| Income tax | $2.53M | -$314,000 | $3.85M | -$1.80M | $6.31M | $8.59M | $9.47M | $6.29M |
| Net income | $14.98M | $23.61M | $16.51M | $48.61M | $39.68M | $37.01M | -$22.49M | $32.70M |
| EBITDA | $62.56M | $69.07M | $66.88M | $91.44M | $89.48M | $91.62M | $79.38M | $85.96M |
| EPS (basic) | 0.44 | 0.69 | 0.48 | — | 1.13 | 1.06 | -0.66 | — |
| EPS (diluted) | 0.43 | 0.69 | 0.48 | — | 1.11 | 1.04 | -0.66 | — |
| Weighted avg. shares (diluted) | 34.60M | 34.15M | 34.43M | — | 35.61M | 35.71M | 33.92M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $14.13M | $21.38M | $8.12M | $17.16M | $58.94M | $23.14M | $31.71M | $46.54M |
| Receivables | $345.07M | $338.73M | $327.78M | $346.08M | $310.17M | $302.26M | $276.24M | $245.27M |
| Inventory | $278.59M | $288.06M | $284.48M | $253.74M | $263.54M | $266.44M | $260.10M | $247.13M |
| Current assets | $801.39M | $810.63M | $774.76M | $770.10M | $778.12M | $737.43M | $702.20M | $671.12M |
| PP&E, net | $535.13M | $532.34M | $533.14M | $536.43M | — | — | — | $465.80M |
| Goodwill | $1.10B | $1.10B | $1.11B | $1.11B | $1.10B | $1.10B | $1.08B | $1.02B |
| Intangibles | $770.09M | $788.84M | $806.34M | $825.43M | $837.70M | $854.54M | $856.21M | $778.29M |
| Total assets | $3.39B | $3.42B | $3.41B | $3.41B | $3.40B | $3.37B | $3.30B | $3.08B |
| Current liabilities | $201.12M | $217.14M | $206.34M | $232.04M | $209.82M | $216.03M | $206.40M | $227.17M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $11,000 | $10.00M |
| Long-term debt | $1.22B | $1.24B | $1.25B | $1.19B | $1.19B | $1.20B | $1.24B | $980.15M |
| Total debt | $1.22B | $1.24B | $1.25B | $1.19B | $1.19B | $1.20B | $1.24B | $990.15M |
| Total liabilities | $1.67B | $1.70B | $1.71B | $1.66B | $1.65B | $1.67B | $1.69B | $1.46B |
| Shareholders' equity | $1.73B | $1.72B | $1.70B | $1.75B | $1.75B | $1.70B | $1.61B | $1.62B |
| Net debt | $1.21B | $1.22B | $1.24B | $1.17B | $1.13B | $1.18B | $1.20B | $943.61M |
| Shares outstanding | 34.00M | 33.99M | 33.95M | 34.35M | 35.04M | 35.03M | 34.89M | 33.55M |
| Cash flow statement | ||||||||
| Operating cash flow | $36.63M | $59.73M | $24.70M | $55.41M | $65.59M | $43.86M | $31.28M | $63.23M |
| Capital expenditure | $20.53M | $22.69M | $23.96M | $27.48M | $19.34M | $19.00M | $25.22M | $19.09M |
| Free cash flow | $16.10M | $37.04M | $737,000 | $27.94M | $46.26M | $24.86M | $6.06M | $44.14M |
| Investing cash flow | -$20.51M | -$22.68M | -$37.90M | -$35.47M | -$20.27M | -$17.83M | -$197.17M | $29.62M |
| Financing cash flow | -$22.42M | -$23.59M | $3.83M | -$61.72M | -$10.71M | -$35.59M | $151.58M | -$82.30M |
| Depreciation & amortization | $34.35M | $34.54M | $35.01M | $35.51M | $33.04M | $32.29M | $29.83M | $28.93M |
| Stock-based compensation | $5.23M | $5.38M | $6.66M | $5.76M | $4.93M | $5.66M | $6.88M | $6.04M |
| Share buybacks | $0 | $0 | $50.00M | $50.01M | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.